News Agency
Men's Weekly

OnCusp Therapeutics Announces First Patient Dosed in Phase 1 Trial of CUSP06 in Patients with Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

  • Written by PR Newswire

--CUSP06 is a CDH6-directed Antibody-Drug Conjugate (ADC) with a differentiated profile and potentially best-in-class activity--

NEW YORK, March 6, 2024 /PRNewswire/ -- OnCusp Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer...

Read more: OnCusp Therapeutics Announces First Patient Dosed in Phase 1 Trial of CUSP06 in Patients with...

How CIOs Can Govern Microsoft 365 Licensing Across Thousands of Endpoints

At enterprise scale, Microsoft 365 licensing is rarely a procurement problem but a governance problem. Organisations managing thousands of endpoints frequently accumulate licence sprawl, misaligned SKUs and underutilised entitlements that together represent significant unrecovered expenditure. Without a structured governance framework... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion